FDA Approves Medtronic's Percept RC Deep Brain Stimulation System
(RTTNews) - The U.S. Food and Drug Administration approved Medtronic plc.'s (MDT) Percept RC Deep Brain Stimulation or DBS system, the company said in a statement.
According to the company, the rechargeable neurostimulator is the latest innovation in the Medtronic Percept family, which includes the Percept PC neurostimulator, BrainSense technology, and SenSight directional leads.
The company noted that the Percept family is the only sensing-enabled DBS system on the market, allowing the physician to personalize treatment for patients with movement disorders such as Parkinson's disease, essential tremor, and dystonia as well as epilepsy.
For More Such Health News, visit rttnews.com
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.